|
Early Access
Pharmaceutical and
biotechnology companies can work with PMI technology
through Aspira's Research Alliance Program.
Collaborative opportunities exist for various application areas, including:
- Protein expression arrays for
analysis of known and unknown proteins
- Novel protein isolation in drug discovery
research
- Protein capture arrays for
post-translational modification characterization
- Protein-protein interaction
assays for target validation in early drug discovery
- Small molecule-protein
interaction assays for compound library screening
- Protein scavenging or
purification in bioprocess development
To learn more about Aspira's technologies, products, or partnering
opportunities, please contact:
Meri Gruber
General Manager
tel:(650) 259-6428
fax: (650) 618-1874
contactus@aspirabio.com
|
|
